With reference to the news article in The Economic Times, on July 22, 2015 captioned ‘Aurobindo Pharma Comes Under US FDA Lens’, Aurobindo Pharma has Clarified that the said facility underwent a routine GMP inspection by USFDA and there are certain observations related to the systems and procedures. The Company is appropriately responding and this has no perceived impact on the operations and exports from the said facility.

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1291.40 43.45 (3.48%)
20-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.45
Dr. Reddys Lab 1298.95
Cipla 1255.85
Zydus Lifesciences 890.60
Lupin 2322.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×